Development and validation of a vaccine hesitancy scale for COVID-19 to the Portuguese language
DOI:
https://doi.org/10.33448/rsd-v12i3.40357Keywords:
Vaccination Hesitancy; Scale; Psychometrics; COVID-19; Validation study.Abstract
This is a psychometric study aimed at developing and validating a specific scale that assesses the vaccine hesitancy behavior of COVID-19 to the Portuguese language. The vaccine hesitancy scale for COVID-19 vaccines was developed in Brazil based on the Vaccine Hesitancy Scale developed by the Strategic Advisory Group of Experts on Immunization Working Group. Data were collected at the end of the first wave of the COVID-19 pandemic in Brazil (between March 1 and June 30 of 2021) by convenience sampling and snowballing using electronic surveys with 1345 participants. We carried out an exploratory factorial analysis (EFA) and confirmatory factorial analysis (CFA) of 10 items. Our findings for the EFA suggested only a single dimension and the unidimensional congruence of 0.95 and explained a common variance of 0.90; all items presented a significant factor loading (≥ 0.30) with excellent reliability (Cronbach’s alpha of 0.88). The CFA showed the model fit indices were satisfactory (x2 = 66.0538, gl = 35, p = 0.001; RMSEA = 0.03 CI [0.02;0.04]); CFI = 0.98; TLI = 0.98) with the factor loadings cut-off ranging from 0.32 to 0.88. Our findings revealed that the vaccinal hesitancy assessment tool for COVID-19 vaccines in the Portuguese language has evidence of internal validity and reliability, and it is best represented as a unifactorial 10-item structure yielding a total score.
References
Akel, K. B., Masters, N. B., Shih, S. F., Lu, Y., & Wagner, A. L. (2021). Modification of a vaccine hesitancy scale for use in adult vaccinations in the United States and China. Hum Vaccin Immunother, 17(8), 2639-2646.
Asparouhov, T., & Muthén, B. (2009). Exploratory Structural Equation Modeling. Structural Equation Modeling: A Multidisciplinary Journal, 16(3), 397-438.
Bagateli, L. E., Saeki, E. Y., Fadda, M., Agostoni, C., Marchisio, P., & Milani, G. P. (2021). COVID-19 Vaccine Hesitancy among Parents of Children and Adolescents Living in Brazil. Vaccines, 9(10), 1115.
Black, S., & Rappuoli, R. (2010). A Crisis of Public Confidence in Vaccines. Science Translational Medicine, 2(61), 61mr61-61mr61.
Brown, T. A. (2006). Confirmatory factor analysis for applied research. New York: Guilford publications.
de Sousa Á, F. L., Teixeira, J. R. B., Lua, I., de Oliveira Souza, F., Ferreira, A. J. F., Schneider, G., et al. (2021). Determinants of COVID-19 Vaccine Hesitancy in Portuguese-Speaking Countries: A Structural Equations Modeling Approach. Vaccines (Basel), 9(10).
Ferrando, P. J., & Lorenzo-Seva, U. (2017). Program FACTOR at 10: Origins, development and future directions. Psicothema, 29(2), 236-240.
Ferrando, P. J., & Lorenzo-Seva, U. (2018). Assessing the Quality and Appropriateness of Factor Solutions and Factor Score Estimates in Exploratory Item Factor Analysis. Educational and Psychological Measurement, 78(5), 762-780.
Gangarosa, E. J., Galazka, A. M., Wolfe, C. R., Phillips, L. M., Gangarosa, R. E., Miller, E., et al. (1998). Impact of anti-vaccine movements on pertussis control: the untold story. Lancet, 351(9099), 356-361.
Gardner, L., Dong, E., Khan, K., & Sarkar, S. (2020). Persistence of US measles risk due to vaccine hesitancy and outbreaks abroad. Lancet Infect Dis, 20(10), 1114-1115.
Hamilton, K., & Hagger, M. S. (2022). The Vaccination Concerns in COVID-19 Scale (VaCCS): Development and validation. PLoS One, 17(3), e0264784.
Harrison, E. A., & Wu, J. W. (2020). Vaccine confidence in the time of COVID-19. Eur J Epidemiol, 35(4), 325-330.
Kotta, I., Kalcza-Janosi, K., Szabo, K., & Marschalko, E. E. (2022). Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale. Hum Vaccin Immunother, 18(1), 1-10.
Larson, H. J., Cooper, L. Z., Eskola, J., Katz, S. L., & Ratzan, S. (2011). Addressing the vaccine confidence gap. The Lancet, 378(9790), 526-535.
Larson, H. J., Jarrett, C., Schulz, W. S., Chaudhuri, M., Zhou, Y., Dube, E., et al. (2015). Measuring vaccine hesitancy: The development of a survey tool. Vaccine, 33(34), 4165-4175.
Lorenzo-Seva, U. (2021). SOLOMON: a method for splitting a sample into equivalent subsamples in factor analysis. Behav Res Methods.
Lorenzo-Seva, U., & Ferrando, P. J. (2019). Robust Promin: a method for diagonally weighted factor rotation. Liberabit, 25, 99-106.
MacDonald, N. E. (2015). Vaccine hesitancy: Definition, scope and determinants. Vaccine, 33(34), 4161-4164.
Machingaidze, S., & Wiysonge, C. S. (2021). Understanding COVID-19 vaccine hesitancy. Nature Medicine, 27(8), 1338-1339.
Moore, D., Nehab, M. F., Camacho, K. G., Reis, A. T., Junqueira-Marinho, M. F., Abramov, D. M., et al. (2021). Low COVID-19 vaccine hesitancy in Brazil. Vaccine, 39(42), 6262-6268.
Qunaibi, E. A., Helmy, M., Basheti, I., & Sultan, I. (2021). A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs. eLife, 10, e68038.
Reckase, M. D. (1985). The Difficulty of Test Items That Measure More Than One Ability. Applied Psychological Measurement, 9(4), 401-412.
Sallam, M. (2021). COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines (Basel), 9(2).
Shapiro, G. K., Tatar, O., Dube, E., Amsel, R., Knauper, B., Naz, A., et al. (2018). The vaccine hesitancy scale: Psychometric properties and validation. Vaccine, 36(5), 660-667.
Teixeira, P. H. M. S., L. B., Cortez, P. J. O., Franca, A. B., & Magalães, V. L. (2021). Hesitação Vacinal Durante a Pandemia da COVID-19 no Brasil. In M. C. Andrade (Ed.), COVID-19, UMA VISÃO TRANSLACIONAL: da pesquisa à clínica (2ª ed., Vol. 2, pp. 61 - 70): Tradição Planalto Produções Visuais e Editoriais.
Ten Great Public Health Achievements --- United States, 2001--2010 (2011, 2011 May 20). Morbidity and Mortality Weekly Report (MMWR) https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6019a5.htm
Timmerman, M. E., & Lorenzo-Seva, U. (2011). Dimensionality assessment of ordered polytomous items with parallel analysis. Psychol Methods, 16(2), 209-220.
Why vaccination is safe and important (2019). https://www.nhs.uk/conditions/vaccinations/why-vaccination-is-safe-and-important/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Angelo Tunin Chica Pergo; Alex Bacadini França; Pedro Henrique Machado Teixeira; Lucas Brites Siqueira; Paulo José Oliveira Cortez; Luciano Magalhães Vitorino
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
